Apex Healthcare Bhd
Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, ant… Read more
Apex Healthcare Bhd (7090) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.038x
Based on the latest financial reports, Apex Healthcare Bhd (7090) has a cash flow conversion efficiency ratio of 0.038x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM29.41 Million) by net assets (RM779.26 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Apex Healthcare Bhd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Apex Healthcare Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Apex Healthcare Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Apex Healthcare Bhd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dimerco Express
TWO:5609
|
0.001x |
|
Villeroy & Boch AG
XETRA:VIB3
|
0.066x |
|
Batu Kawan Bhd
KLSE:1899
|
-0.028x |
|
Jilin Expressway Co Ltd
SHG:601518
|
0.038x |
|
Wuxi Lihu Corporation Limited Class A
SHE:300694
|
-0.019x |
|
Grand Korea Leisure Co. Ltd
KO:114090
|
0.082x |
|
PT Daya Intiguna Yasa Tbk
JK:MDIY
|
0.121x |
|
Rocky Brands Inc
NASDAQ:RCKY
|
-0.014x |
Annual Cash Flow Conversion Efficiency for Apex Healthcare Bhd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Apex Healthcare Bhd from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | RM789.62 Million | RM69.00 Million | 0.087x | +23.08% |
| 2023-12-31 | RM918.27 Million | RM65.19 Million | 0.071x | -44.99% |
| 2022-12-31 | RM558.43 Million | RM72.07 Million | 0.129x | +5.82% |
| 2021-12-31 | RM506.86 Million | RM61.82 Million | 0.122x | -33.24% |
| 2020-12-31 | RM467.97 Million | RM85.49 Million | 0.183x | +13.81% |
| 2019-12-31 | RM425.53 Million | RM68.30 Million | 0.161x | +53.12% |
| 2018-12-31 | RM385.99 Million | RM40.46 Million | 0.105x | -22.33% |
| 2017-12-31 | RM343.23 Million | RM46.32 Million | 0.135x | +24.58% |
| 2016-12-31 | RM311.97 Million | RM33.80 Million | 0.108x | +35.65% |
| 2015-12-31 | RM288.00 Million | RM23.00 Million | 0.080x | -40.67% |
| 2014-12-31 | RM260.00 Million | RM35.00 Million | 0.135x | +17.17% |
| 2013-12-31 | RM235.00 Million | RM27.00 Million | 0.115x | -19.95% |
| 2012-12-31 | RM216.00 Million | RM31.00 Million | 0.144x | -- |